Compared with inhalation anesthesia with sevoflurane, TIVA with propofol/remifentanil effectively inhibited the release of VEGF-C induced by breast cancer surgery, but did not significantly affect the 2-year RFS rate, suggesting that it does not affect short-term breast cancer recurrence (88). The gene discussed is VEGFC; the disease is breast cancer.